Erich Sabio - Concepedia

Concepedia

Author

Erich Sabio

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Erich A. Sabio, Erich Sabio, Erich Y. Sabio

45

Publications

1.6K

Citations

13

H-Index

36

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cleveland Clinic Icahn School of Medicine at Mount Sinai California State University, Fullerton Stanford University

ES

About

Erich Sabio is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Immunology	4	4	1.2K
3	Natural Sciences	2	2	76
4	Biology	2	2	76
5	Cell Biology	1	1	74

Erich Sabio

×

12

Publications

1.6K

Citations

12

H-Index

	Year	Citations
Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response Rajarsi Mandal, Robert Samstein, Ken-Wing Lee, Science ImmunodeficienciesImmunologyPathologyMismatch Repair DeficiencyImmunotherapy	2019	564
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity Sydney X. Lu, Emma De Neef, James D. Thomas, Cell ImmunologyRna SplicingTumor ImmunitySplicing VariantMedicine	2021	267
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types Diego Chowell, Seong‐Keun Yoo, Cristina Valero, Nature Biotechnology Cancer ImmunosurveillanceMedicineImmunologyMultiple Cancer TypesImmune Checkpoint Inhibitor	2021	254
An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis Logan A. Walsh, Mariano J. Alvarez, Erich Sabio, Cell Reports	2017	114
A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis Virginie Olive, Erich Sabio, M Bennett, eLife	2013	81
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity Xiaoxiao Ma, Nadeem Riaz, Robert Samstein, Nature Genetics Pold1 MutationsImmunotherapyMedicineImmunologyTumor Immunity	2022	74
The periplasmic regulator ExoR inhibits ExoS/ChvI two‐component signalling in <i>Sinorhizobium meliloti</i> Esther J. Chen, Erich Sabio, Sharon R. Long Molecular Microbiology	2008	68
Identification of Direct Transcriptional Target Genes of ExoS/ChvI Two-Component Signaling in <i>Sinorhizobium meliloti</i> Esther J. Chen, Robert F. Fisher, Virginia M. Perovich, Journal of Bacteriology GeneticsTranscriptional RegulationSinorhizobium Meliloti Exos/chviSignaling PathwayExos/chvi Regulation	2009	53
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma Phillip M. Rappold, Lynda Vuong, Josef Leibold, Cancer Discovery	2022	29
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias Won Jun Kim, Edie I. Crosse, Emma De Neef, Cell	2025	24

Page 1